Brief: Eiger Biopharmaceuticals Announces Multiple Presentations At The European Association For The Study Of The Liver
08/06/2022 13:32
June 8 (Reuters) - Eiger BioPharmaceuticals Inc EIGR.O :
* EIGER BIOPHARMACEUTICALS ANNOUNCES MULTIPLE PRESENTATIONS
AT THE
EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER (EASL)
INTERNATIONAL LIVER CONGRESS™ 2022
Source text for Eikon: ID:nPn3JZtKPa
Further company coverage: EIGR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Eiger Biopharmaceuticals
See all newsBrief: Eiger Biopharmaceuticals On Sept 5, Bankruptcy Court Entered Order Confirming Fifth Amended Joint Plan Of Liquidation Of Co & Its Debtor Affiliates
Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar
Brief: Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Eiger BioPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eiger BioPharmaceuticals Inc expected to post a loss of $7.50 a share - Earnings Preview